Immunosignaturing Can Detect Products from Molecular Markers in Brain Cancer

Immunosignaturing shows promise as a general approach to diagnosis. It has been shown to detect immunological signs of infection early during the course of disease and to distinguish Alzheimer’s disease from healthy controls. Here we test whether immunosignatures correspond to clinical classificatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Hughes, Alexa K., Cichacz, Zbigniew, Scheck, Adrienne, Coons, Stephen W., Johnston, Stephen Albert, Stafford, Phillip
Format: Artigo
Language:Inglês
Published: Public Library of Science 2012
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3397978/
https://ncbi.nlm.nih.gov/pubmed/22815729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0040201
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items